Skip to main content
. 2019 Jan 31;294(13):5198–5207. doi: 10.1074/jbc.RA118.006601

Figure 3.

Figure 3.

Re-expression of APE1WT but not APE1C65S or APE1E96A mutant forms restores the ability of APE1-null CH12F3 cells to undergo isotype switching. A–C, representative dot plots (A), percentages of CD19/IgA double-positive cells (B), and amounts of released IgA (C) by switching CH12F3 APE1+/+/Δ and CH12F3 APE1Δ/Δ/Δ cells under CIT(−) and CIT(+) conditions. D–F, representative dot plots (D), percentages of GFP/IgA double-positive cells (E), and amounts of released IgA (F) by CH12F3 APE1+/+/Δ transfected with empty vector or with GFP-APE1WT, APE1C65S, or APE1E96A mutant forms and induced toward IgA switching. G–I, representative dot plots (G), percentages of GFP/IgA double-positive cells (H), and amounts of released IgA (I) by CH12F3 APE1Δ/Δ/Δ transfected with empty vector, GFP-APE1WT, APE1C65S, or APE1E96A mutant forms and induced toward IgA switching. The data are representative of four independent experiments. *, p < 0.05; **, p < 0.005; ***, p < 0.001; ns, not significant.